Organigram Global Inc. announces a proposed acquisition of Aurora Cannabis Inc., following a hostile takeover attempt by Curaleaf Holdings. Multiple outlets report that Organigram and Aurora enter an agreement valuing Aurora at about $561 million, with the deal described as “friendly” in contrast to Curaleaf’s earlier move.
The coverage focuses on the shift from a confrontation—where Organigram previously sought to fend off Curaleaf—to a signed arrangement agreement. BNN Bloomberg and Seeking Alpha both frame the story around the transition from hostile to friendly terms, while other outlets emphasize the headline value of the transaction.
Across sources, the key context is that the attempt traces to Curaleaf’s hostile bid and that Organigram is now moving forward through an arrangement agreement with Aurora. Outlets vary primarily in wording and emphasis, including whether they highlight Organigram’s prior defensive posture or the goal of building a global cannabis business leader.
